Literature DB >> 8203679

The urgent need for a vaginal microbicide in the prevention of HIV transmission.

M Potts.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8203679      PMCID： PMC1614934          DOI： 10.2105/ajph.84.6.890

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  13 in total

1.  Heterosexual transmission of HIV.

Authors:  B Voeller; D J Anderson
Journal:  JAMA       Date:  1992-04-08       Impact factor: 56.272

2.  Epidemiology of women with AIDS in the United States, 1981 through 1990. A comparison with heterosexual men with AIDS.

Authors:  T V Ellerbrock; T J Bush; M E Chamberland; M J Oxtoby
Journal:  JAMA       Date:  1991-06-12       Impact factor: 56.272

3.  The use of spermicide containing nonoxynol-9 in the prevention of HIV infection.

Authors:  K D Bird
Journal:  AIDS       Date:  1991-07       Impact factor: 4.177

4.  HIV prevention: the need for methods women can use.

Authors:  Z A Stein
Journal:  Am J Public Health       Date:  1990-04       Impact factor: 9.308

5.  The protective effect of nonoxynol-9 against HIV infection.

Authors:  P J Feldblum; S S Weir
Journal:  Am J Public Health       Date:  1994-06       Impact factor: 9.308

6.  Effect of the contraceptive sponge on chlamydial infection, gonorrhea, and candidiasis. A comparative clinical trial.

Authors:  M J Rosenberg; W Rojanapithayakorn; P J Feldblum; J E Higgins
Journal:  JAMA       Date:  1987-05-01       Impact factor: 56.272

7.  Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms.

Authors:  M J Rosenberg; A J Davidson; J H Chen; F N Judson; J M Douglas
Journal:  Am J Public Health       Date:  1992-05       Impact factor: 9.308

8.  A dosing study of nonoxynol-9 and genital irritation.

Authors:  R E Roddy; M Cordero; C Cordero; J A Fortney
Journal:  Int J STD AIDS       Date:  1993 May-Jun       Impact factor: 1.359

9.  Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes.

Authors:  J Kreiss; E Ngugi; K Holmes; J Ndinya-Achola; P Waiyaki; P L Roberts; I Ruminjo; R Sajabi; J Kimata; T R Fleming
Journal:  JAMA       Date:  1992 Jul 22-29       Impact factor: 56.272

10.  Comparative in vitro study of contraceptive agents with anti-HIV activity: gramicidin, nonoxynol-9, and gossypol.

Authors:  A S Bourinbaiar; S Lee-Huang
Journal:  Contraception       Date:  1994-02       Impact factor: 3.375
View more
  14 in total

1.  Thinking about vaginal microbicide testing.

Authors:  M Potts
Journal:  Am J Public Health       Date:  2000-02       Impact factor: 9.308

2.  Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue.

Authors:  Charles Dobard; Sunita Sharma; Amy Martin; Chou-Pong Pau; Angela Holder; Zsuzsanna Kuklenyik; Jonathan Lipscomb; Debra L Hanson; James Smith; Francis J Novembre; J Gerardo García-Lerma; Walid Heneine
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  Development of a new methodology for screening of human immunodeficiency virus type 1 microbicides based on real-time PCR quantification.

Authors:  Renato S Aguiar; Luciana J Costa; Helena S Pereira; Rodrigo M Brindeiro; Amilcar Tanuri
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

4.  The protective effect of condoms and nonoxynol-9 against HIV infection.

Authors:  K M Wittkowski; E Susser; K Dietz
Journal:  Am J Public Health       Date:  1998-04       Impact factor: 9.308

5.  Socioecological influences on community involvement in HIV vaccine research.

Authors:  Paula M Frew; Matthew Archibald; Brooke Hixson; Carlos del Rio
Journal:  Vaccine       Date:  2011-06-29       Impact factor: 3.641

6.  The microbicidal agent C31G inhibits Chlamydia trachomatis infectivity in vitro.

Authors:  P B Wyrick; S T Knight; D G Gerbig; J E Raulston; C H Davis; T R Paul; D Malamud
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

7.  A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NY.

Authors:  M N Gourevitch; D Hartel; E E Schoenbaum; P A Selwyn; K Davenny; G H Friedland; R S Klein
Journal:  Am J Public Health       Date:  1996-08       Impact factor: 9.308

8.  Chemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptase.

Authors:  G Borkow; J Barnard; T M Nguyen; A Belmonte; M A Wainberg; M A Parniak
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

9.  An extended model of reasoned action to understand the influence of individual- and network-level factors on African Americans' participation in HIV vaccine research.

Authors:  Paula M Frew; Matthew Archibald; Dazon Dixon Diallo; Su-I Hou; Takeia Horton; Kayshin Chan; Mark J Mulligan; Carlos del Rio
Journal:  Prev Sci       Date:  2010-06

10.  Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine.

Authors:  Urvi M Parikh; Charles Dobard; Sunita Sharma; Mian-er Cong; Hongwei Jia; Amy Martin; Chou-Pong Pau; Debra L Hanson; Patricia Guenthner; James Smith; Ellen Kersh; J Gerardo Garcia-Lerma; Francis J Novembre; Ron Otten; Thomas Folks; Walid Heneine
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.